Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.08
+0.23 (0.96%)
Mar 18, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $77.91 million as of March 18, 2026. Its market cap has increased by 530.49% in one year.
Market Cap
77.91M
Enterprise Value
67.19M
1-Year Change
530.49%
Ranking
Category
Stock Price
$24.08
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $77.91M, an increase of 181.43%. That is a compound annual growth rate of 64.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 77.17M | -19.35% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 83.63M |
| PMV Pharmaceuticals | 83.19M |
| Seres Therapeutics | 83.02M |
| iBio, Inc. | 82.56M |
| Pliant Therapeutics | 81.11M |
| Annovis Bio | 80.25M |
| PolyPid | 80.10M |
| NeurAxis | 75.10M |